Cancer Biology, Epidemiology, Computational Biology
Highest Education Qualification
Ph.D
PhD University
Thapar Institute of Engineering and Technology, Patiala
PhD Completion Year
2022
Teaching Experience Years
9
Research Experience Years
1
Subjects Taught
Cancer Biology, OMICS, Clinical Biochemistry
Research Domain
Cancer Biology, Epidemiology, Computational Biology
Research Details
1. Research Papers / Publications
Garg S., Jaiswal A., Sarkhel Samuel J., Singh J., & Singh S. Modeling hexavalent chromium removal from aqueous systems using a fixed bed of immobilized bacteria and zero-valent iron nanoparticles. 3 Biotech, 15, 372 (2025). (IF 2.9)
Gund V., Sharma S., Chandan S., Garg S., Singh S. Identification of non-synonymous SNPs affecting structure and function of MLH1 and NBN proteins: a computational approach. Journal of Applied Genetics. 2025.
Kaur I., Kansal H., Singh S., Singh N., & Sharma S. Association of hTERT MNS16A polymorphism with clinical outcomes of North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Clinical and Translational Oncology. 2024. (IF 2.8)
Singh S., Singh N., Sharma S. Genetic polymorphism in mismatch repair genes as a modulator of lung cancer risk in North Indians undergoing platinum-based chemotherapy. Nucleosides, Nucleotides & Nucleic Acids. Under Review. (IF 1.167)
Kirthiga SS., Patil S., Singh S., et al. Enhancing Cancer Immunotherapy: Exploring Strategies to Target the PD-1/PD-L1 Axis. European Journal of Pharmaceutics and Biopharmaceutics. 2024. (IF 4.38)
Singh S., Singh N., Gupta PSS., et al. Assessing the impact of MSH3 and MSH6 polymorphisms on lung cancer risk in North Indian patients undergoing platinum chemotherapy. Scientific Reports. 2024. (IF 3.8)
Singh S., Baranwal M., Singh N., Sharma S. MSH3 and MSH6 gene polymorphisms: Association with lung cancer susceptibility and prognostic value. Journal of Clinical Oncology. 2023. (IF 50.717)
Yadav H., Pandit D., Singh S., et al. GST polymorphism as a predictive biomarker for COPD susceptibility: A North Indian study. Experimental Physiology. 2023. (IF 2.7)
Singh S., Sharma S., Baranwal M., Kataria S. Understanding immune checkpoints and PD-1/PD-L1 mediated immune resistance towards tumor immunotherapy. 3 Biotech. 2023. (IF 2.8)
Singh S., Gupta A., Singh N., et al. Genotyping and molecular dynamics simulation of SNPs of MGMT and ERCC1 gene in lung cancer patients. Journal of Biomolecular Structure and Dynamics. 2023. (IF 4.5)
Singh S., Singh N., Baranwal M., Sharma S. Association of MLH1-93G>A polymorphisms toward lung cancer susceptibility. Journal of Cancer Research and Therapeutics. 2023. (IF 1.331)
Singh S., Sharma S., Lawania S., Singh N. SNPs of nucleotide excision repair genes and overall survival in lung cancer patients. Journal of Cancer Research and Therapeutics. 2023. (IF 1.331)
Singh S., Singh N., Sharma S. Genetic polymorphisms in the Mismatch Repair Pathway contribute to chemotherapy toxicity. Journal of Biochemical and Molecular Toxicology. 2022. (IF 3.568)
Singh S., Singh N., Baranwal M., Sharma S. Structural and functional analysis of MSH6 polymorphisms in lung cancer patients. The American Journal of the Medical Sciences. 2022. (IF 3.462)
Singh S., Sharma S., Baranwal M. Identification of SNPs in hMSH3/MSH6 interaction domain affecting MSH2 protein. Biotechnology and Applied Biochemistry. 2022. (IF 2.724)
Singh S., Baranwal M., Singh N., Sharma S. Polymorphisms in the MSH2 gene predict poor survival in lung cancer patients undergoing chemotherapy. Biomarkers in Medicine. 2022. (IF 2.498)
Kashyap S., Kumar V., Abraham S., et al. Microwave Reduced Graphene Oxide as Efficient NIR Photothermal Agent. Austin Journal of Biosensors & Bioelectronics. 2017.
Singh S., Sharma M., Kumar S., Gowal D. Standardization of serum neutralization assay of Japanese encephalitis virus on BHK-21 cell line. Acta Virologica. 2015. (IF 1.82)